Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Usefulness of Combined Measurement of Surfactant Protein D, Thrombin-Antithrombin III Complex, D-Dimer, and Plasmin-α2 Plasmin Inhibitor Complex in Acute Exacerbation of Interstitial Lung Disease: A Retrospective Cohort Study.
Takeshita Y, To M, Kurosawa Y, Furusho N, Kinouchi T, Tsushima K, Tada Y, To Y, Sakao S. Takeshita Y, et al. Among authors: kinouchi t. J Clin Med. 2024 Apr 21;13(8):2427. doi: 10.3390/jcm13082427. J Clin Med. 2024. PMID: 38673700 Free PMC article.
Combination therapy with predicted body weight-based dexamethasone, remdesivir, and baricitinib in patients with COVID-19 pneumonia: A single-center retrospective cohort study during 5th wave in Japan.
Hirasawa Y, Terada J, Shionoya Y, Fujikawa A, Isaka Y, Takeshita Y, Kinouchi T, Koshikawa K, Tajima H, Kinoshita T, Tada Y, Tatsumi K, Tsushima K. Hirasawa Y, et al. Among authors: kinouchi t. Respir Investig. 2023 Jul;61(4):438-444. doi: 10.1016/j.resinv.2023.03.009. Epub 2023 Apr 18. Respir Investig. 2023. PMID: 37119744 Free PMC article.
Development of a novel score model to predict hyperinflammation in COVID-19 as a forecast of optimal steroid administration timing.
Takeshita Y, Terada J, Hirasawa Y, Kinoshita T, Tajima H, Koshikawa K, Kinouchi T, Isaka Y, Shionoya Y, Fujikawa A, Kato Y, To Y, Tada Y, Tsushima K. Takeshita Y, et al. Among authors: kinouchi t. Front Med (Lausanne). 2022 Aug 9;9:935255. doi: 10.3389/fmed.2022.935255. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36017008 Free PMC article.
Favipiravir, camostat, and ciclesonide combination therapy in patients with moderate COVID-19 pneumonia with/without oxygen therapy: An open-label, single-center phase 3 randomized clinical trial.
Terada J, Fujita R, Kawahara T, Hirasawa Y, Kinoshita T, Takeshita Y, Isaka Y, Kinouchi T, Tajima H, Tada Y, Tsushima K. Terada J, et al. Among authors: kinouchi t. EClinicalMedicine. 2022 Jul;49:101484. doi: 10.1016/j.eclinm.2022.101484. Epub 2022 Jun 3. EClinicalMedicine. 2022. PMID: 35692220 Free PMC article.
High-flow nasal cannula oxygen therapy in hypoxic patients with COVID-19 pneumonia: A retrospective cohort study confirming the utility of respiratory rate index.
Takeshita Y, Terada J, Hirasawa Y, Kinoshita T, Tajima H, Koshikawa K, Kinouchi T, Isaka Y, Shionoya Y, Tada Y, Tsushima K. Takeshita Y, et al. Among authors: kinouchi t. Respir Investig. 2022 Jan;60(1):146-153. doi: 10.1016/j.resinv.2021.10.005. Epub 2021 Oct 30. Respir Investig. 2022. PMID: 34772644 Free PMC article.
365 results